15/02/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

15/02/2024

Feb 15, 2024, 19:00 | Blog
Albert Ananyan: Honored to be a part of the first-ever global Oncothon
Albert Ananyan, Student of Masters of Management Science in Global Affairs at Schwarzman Scholars, shared…
Feb 15, 2024, 18:50 | Opinion
Jemma Arakelyan: 15th of February is International Childhood Cancer Day. Let’s make the Oncothon an extraordinary success and pave the path to a future where no child has to face cancer alone!
Feb 15, 2024, 18:46 | Blog
Sarah Sammons: Patients with adverse financial events were more likely to have later-stage diagnosis
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post on X/Twitter: ''1/3…
Feb 15, 2024, 18:42 | Drugs
Alex Bataller: Phase 1/2 trial results of oral decitabine/cedazuridine with venetoclax in higher risk MDS and CMML
Alex Bataller, Leukemia fellow at Leukemia Department, MD Anderson Cancer Center (Houston, Texas), shared a…
Feb 15, 2024, 18:35 | Insight
Nina Niu Sanford: The best way to advocate for radiotherapy is through better evidence demonstrating the value of our modality
Nina Niu Sanford, Assistant Professor of Radiation Oncology at UT Southwestern Medical Center, shared an…
Feb 15, 2024, 18:33 | Blog
Paolo Tarantino: So glad to join outstanding colleagues and friends for productive discussions on the evolving treatment landscape for breast cancer at JSMO24
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared an X post by Kazuki…
Feb 15, 2024, 18:29 | Blog,Insight
The MARGOT is optimizing preoperative therapy for Stage II-III HER2+ breast cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X/Twitter: ''The MARGOT study led by Dana-Farber’s…
Feb 15, 2024, 18:26 | Blog
Fumiko Ladd Chino: Haydeé Verduzco writes about the gap between her excitement for new treatments presented at medical conferences
Fumiko Ladd Chino shared a post on X/Twitter: ''Haydeé Verduzco writes about the gap between…
Feb 15, 2024, 18:08 | Career
Amalya Sargsyan: An email that every young oncologist imagines getting
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared on LinkedIn: "Not long ago,…
Feb 15, 2024, 18:04 | Societies
ASCO members, we want to hear from you - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on LinkedIn: "ASCO members: We want to hear from…
All: 26 Posts: 1 - 10